LaRocca John - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 16, 2025, LaRocca John's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Officer (SVP, General Counsel & Secry), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other YMAB insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

LaRocca John - Insider Non-Derivative Transactions of YMAB Common Stock

LaRocca John - Insider Non-Derivative Transactions at YMAB

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Sep 17, 2025	Disposition -- (Common Stock)	21500	0	0
Jan 18, 2025	Acquisition -- (Common Stock)	21500	0	21500